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By Anna Corcione, Luciano Ottonello, Giuseppe Tortolina, Paola Tasso, Fabio Ghiotto, Irma Airoldi,
Giuseppe Taborelli, Fabio Malavasi, Franco Dallegri, and Vito Pistoia
Recent studies performed in mice knocked out for the tumor Accordingly, type I and II TNF receptors (TNFRs) were de-
necrosis factor (TNF), the lymphotoxin-a, or the type I TNF tected by ﬂow cytometry on the surface of memory and
receptor (R), genes have shown that these animals display naive, but not GC, B lymphocytes. Blocking experiments
gross defects in germinal center (GC) formation, suggesting with monoclonal antibodies to type I or II TNFR showed that
that members of the TNF and TNFR superfamilies are in- rTNF enhanced the spontaneous chemotaxis of memory and
volved in the control of B-cell migration. Based on these naive B cells through the selective engagement of type II
premises, we have here investigated the effects of human TNFR. Finally, the TNF gene was found to be expressed in
recombinant (r) TNF on the polarization and locomotion of memory, naive and GC B lymphocytes; the cytokine was
tonsillar B cells. rTNF increased the spontaneous polariza- released in culture supernatants from the three B-cell sub-
tion and locomotion of unfractionated tonsillar B lympho- sets after stimulation. These data may support the hypothe-
cytes in a dose-dependent manner by inducing a true chemo- sis that human TNF is involved in the paracrine and perhaps
tactic response. Memory (IgD
ì, CD38
ì) and naive (IgD
", autocrine control of B-cell migration in secondary lymphoid
CD38
ì), but not GC (IgD
ì, CD38
") B cells puriﬁed from tissues.
total tonsillar B lymphocytes, showed a signiﬁcantly higher
q 1997 by The American Society of Hematology.
locomotion in the presence than in the absence of rTNF.
form organized networks of follicular dendritic cells (FDC) L and GC.
13
EUKOCYTE MIGRATION is a nonrandom process that
depends on cell-to-cell interactions through speciﬁc
In addition, mice knocked out for the type I TNF receptor sets of adhesion molecules and on the binding of integrin
(TNFR) do not develop GC or Peyer’s patches, but form receptors to the extracellular matrix.
1,2 In response to chemo-
lymph nodes.
15 All of the above observations suggest that tactic signals originating outside the venules, leukocytes
members of the TNF and TNFR superfamilies play a pivotal egress from the vascular compartment by a process known as
role in cell trafﬁcking within the secondary lymphoid tissues. diapedesis and localize to the tissues where an inﬂammatory
Here we have addressed this issue in a human model by process is ongoing.
1,2 Mature lymphocytes are known to re-
investigating the in vitro migration of tonsillar B lympho- circulate continuously, moving to the tissues and returning
cytes in the presence or absence of recombinant (r) TNF. back to the blood at least once a day.
1 Discrete lymphocyte
TNF has been shown previously to serve as a chemoattrac- subsets, such as naive and memory B and T cells, display a
tant for human granulocytes,
16 and monocytes,
16 as well as differential tissue tropism which is related to the interaction
for murine ﬁbroblasts
17 and Langerhans cells.
18 No informa- of speciﬁc surface receptors, also known as ‘‘lymphocyte
tion is so far available on the effects of the cytokine on the homing receptors,’’ with complementary endothelial cell ad-
locomotion of human B cells. hesion molecules.
1,2
We show that rTNF stimulates the in vitro migration of In the secondary lymphoid tissues, B lymphocytes settle
human B lymphocytes through the selective engagement of predominantly in three anatomical areas, namely the germi-
the type II TNFR. The chemotactic activity of the cytokine nal center (GC), the follicular mantle (FM), and the marginal
was directed to memory and naive, but not GC, B cells. zone (MZ) in the spleen or its equivalent in other organs,
Finally, memory, naive, and GC B lymphocytes were found such as, for example, the subepithelial area of tonsils.
3-9
to express the TNF gene. Functionally, the GC is the site of hypermutation of Ig vari-
able (V) region genes and afﬁnity maturation of antibody
response
4-8; the FM contains naive B cells that have not yet
From Laboratory of Oncology and Division of Otolaryngology, encountered speciﬁc antigen,
9 and the MZ or its equivalent
Institute G. Gaslini, Genova; the Department of Internal Medicine, harbor memory B cells.
9-11 GC, FM, and MZ B cells can be
University of Genova, Genova; and Institute of Biology and Genet- puriﬁed from human tonsils as IgD
0, CD38
/; IgD
/, CD38
0
ics, University of Ancona, Ancona, Italy.
and IgD
0, CD38
0 cells, respectively.
7-8,11-12 Futhermore, GC, Submitted March 10, 1997; accepted July 25, 1997.
FM, and MZ B cells can be dissected by monoclonal antibod- Supported by grants from Italian National Research Council
ies (MoAbs) into additional subpopulations.
8
(C.N.R.), Progetto Finalizzato A.C.R.O.; and Associazione Italiana
Recent studies performed in mice knocked out for tumor Ricerca sul Cancro and Progetto Ricerca Corrente, Italian Ministry
of Health. necrosis factor (TNF)
13 or lymphotoxin-a (LT-a)
14,15 genes
Address reprint requests to Anna Corcione, PhD, Laboratory of have shown that these animals display gross abnormalities in
Oncology, Scientiﬁc Institute G. Gaslini, Largo G. Gaslini, 5-16148 the development of secondary lymphoid tissues, with some
Genova, Italy. differences in the two experimental models. In particular,
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14,15 TNF-deﬁcient mice q 1997 by The American Society of Hematology.
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spherical outline were scored as polarized and expressed as a per- MATERIALS AND METHODS
centage of the total number of cells counted.
25,26
Cell separation and culture. Mononuclear cells were isolated
In some experiments, freshly puriﬁed B cells were incubated with
from surgically removed tonsils on Ficoll-Hypaque density gradients
or without 1 ng/mL TNF for 20 minutes at 377C and ﬁxed with 10%
and depleted of T cells by rosetting with neuraminidase-treated sheep
formaldehyde. Cell polarization was determined by ﬂow cytometry
erythrocytes. Non T cells were subsequently deprived of monocytes as change in the proﬁle of forward scatter (FSC).
27 An aliquot of
and natural killer (NK) cells by incubation with CD68 and CD56 the same cell suspensions was stained with a CD19 MoAb to check
MoAbs (see below) followed by rosetting with ox erythrocytes their positivity.
coated with a goat antimouse Ig antiserum.
19 The resulting cell prepa- Migration assay. Cell locomotion was studied using the leading
rations consistently contained more than 97% B cells, as assessed front method.
28 Tests were performed in duplicate using blind well
by staining with a CD19 MoAb (see below). chambers (Nucleopore, Cambridge, MA) with an 8-mm pore size
All of the separation procedures were performed at 47C to prevent cellulose ester ﬁlter (Millipore, Milano, Italy) separating the cells
spontaneous apoptosis of GC B cells. Fractionation of tonsillar B (4 1 10
5) from the chemoattractants tested at different concentrations
lymphocytes into FM (naive), GC, and MZ (memory) cells
12 was or from medium alone. After incubation for 2 hours at 377C, the
performed as follows. Naive B lymphocytes were isolated as IgD
/
ﬁlters were ﬁxed in ethanol, stained with Harris haematoxylin, and
cells from puriﬁed B-lymphocyte suspensions by immune rosetting.
12
cleared with xylene. Cell migration was measured as the distance
The IgD
0 B-cell fractions were further separated into CD38
/ (GC between the top of the ﬁlter and the plane in which two or more
cells) and CD38
0 (memory cells) by immune rosetting.
12
nuclei of the faster cells were in focus (400 1 original magniﬁca-
In some experiments, puriﬁed B-cell subsets were cultured (1 1 tion). Five randomly chosen ﬁelds were read for each ﬁlter. The
10
6/mL) for 48 hours in RPMI 1640 medium (Seromed-Bio- results were then pooled and the mean was determined. In some
chromKG, Berlin, Germany) supplemented with L-glutamine, peni- experiments, B-cell fractions were preincubated with antitype I
cillin and streptomycin, nonessential aminoacids and 10% fetal calf TNFR (10 mg/mL), antitype II TNFR (10 mg/mL) or both MoAbs
serum (FCS; Seromed) in the presence or absence of the following for 30 minutes at 47C and washed. Thereafter, the migration assays
stimuli: a CD40 MoAb and recombinant interleukin-4 (rIL-4; Gen- were carried out as described above. In some experiments, the viabil-
zyme, Milan, Italy; 100 U/mL)
7,20,21 or phorbol 12-myristate 13- ity of the tonsillar B-cell fractions was checked by trypan blue
acetate (PMA) (10 ng/mL) and the A23187 calcium ionophore (0.5 staining.
mg/mL), both from Sigma Chemical Co (St Louis, MO). Collagen gel invasion assay. Type I collagen solution was from
MoAbs and immunoﬂuorescence analysis. The murine MoAbs Sigma (Cat. C4580, Lot. 126H4667). Gels were prepared according
used in this study were: CD19 and CD3 from Becton Dickinson to Sigma protocol. Brieﬂy, 800 mL collagen solution were mixed
(San Jose ´, CA); CD56, anti-HLA-DR and CD10 from Coulter (Hia- with 100 mL1 0 1Earle’s buffered saline and 100 mL reconstitution
leah, FL); CD23, CD68 and antihuman IgM and IgG from Dako buffer (2.2% sodium bicarbonate in 0.8 N sodium hydroxide) in
(Glostrup, Denmark); CD39 from Immunotech (Marseille Luminy, order to restore the collagen to physiological pH and osmolarity.
France). The CD38 MoAb used throughout this study (clone IB4) Thereafter, collagen solution (ﬁnal gel concentration 0.88 mg/mL)
has been produced by one of us (F.M.).
22 The CD40 MoAb was was allowed to gel in 24-well plates in absence or presence of the
kindly donated by Dr Maria Grazia Roncarolo (DNAX, Palo Alto, chemoattractants (1 ng/mL rTNF or 100 U/mL rIL-4) in duplicate.
CA). The antihuman IgD MoAb was a generous gift of Dr Maria After geliﬁcation, cells (8 1 10
5/well) were overlaid on the gel
Elisabetta Cosulich (Monoclonal Antibody Unit, CBA, Genova, It- surface and incubated at 377C for 10 hours. At the end of incubation,
aly). gels were ﬁxed for 30 minutes with 2.5% glutaraldehyde and cell
In brief, 5 1 10
5 cells were treated at 47C for 30 minutes with migration was measured as the distance between the top of the gel
optimal concentrations of MoAbs, washed twice in phosphate-buf- and the plane in which the two faster cells invading the gel were in
fered saline supplemented with 2% FCS and further incubated with focus (100 1 original magniﬁcation).
29
a ﬂuorescein isothiocyanate (FITC)-conjugated goat antimouse Ig Checkerboard analysis. Assays of cell migration with different
(Dako) as second reagent. Stained cells were analyzed by ﬂow cy- doses of rTNF (0, 0.1, 1 ng/mL) on both sides of the ﬁlter were also
tometry with a FACScan (Becton Dickinson). Controls were un- performed. The results of these experiments were collected in a
treated cells, cells treated with the FITC-second reagent alone, and checkerboard form by which chemokinesis (ie, change in the inten-
cells treated with irrelevant isotype-matched MoAbs followed by sity of random locomotion) and true chemotaxis (ie, change in the
the FITC-second reagent. In additional experiments, the surface ex- directional response to the stimulus) were calculated according to
pression of TNFRs by freshly isolated B-cell subsets was investi- Zigmond and Hirsch.
25
gated. Cells were treated with a stripping solution
23 for 2 to 3 minutes RNA analysis by reverse transcriptase-polymerase chain reaction
at 47C to remove membrane-bound TNF, incubated with MoAbs to (RT-PCR). Total RNA was extracted from B cells according to Chom-
type I (htr-9), type II (utr-1) TNFR
24 (kindly provided by Dr Manfred czynski and Sacchi
30 and reverse transcribed into cDNA by means of
Brockaus, Hoffman-La Roche, Basel, Switzerland) or with an iso- a commercial kit (Clontech, Palo Alto, CA) using oligo dT as primer.
type-matched MoAb of irrelevant speciﬁcity and subsequently Each cDNA was then diluted to a ﬁnal volume of 100 mLa n dt h e
stained as above. Both the htr-9 and utr-1 MoAbs express the IgG1 efﬁciency of reverse transcription was evaluated by ampliﬁcation of
5 mL of cDNA with the glyceraldehyde-3-phosphate-dehydroge- isotype.
24
Polarization assay. The puriﬁed B-cell fractions were resus- nase(G3PDH) primers supplied with the kit. Afterwards, for each PCR
analysis, 5 mL of cDNA were ampliﬁed in a 50-mL reaction by adding pended in RPMI 1640 medium supplemented with 0.1% bovine
serum albumin (Sigma) and mixed with rTNF (BioSource Interna- 25 pmol of each speciﬁc primer and2Uo fT a qp o l y m e r a s e( C l o n t e c h ) .
The primers used were the following: TNF: forward GAGCACTGA- tional, Camarillo, CA) (0, 0.1, 1, 10, 100, 1,000 ng/mL) or rIL-4
(100 U/mL). Experiments were performed using polystyrene round AAGCATGATCCG and reverse CGAGAAGATGATCTGACT-
CGGT; TNFR type I: forward GCTCCTGGAGCTGTTGGTGGGAA bottom tubes (LP Italiana, Milano, Italy). The tubes, containing 200
mL cell suspension, were incubated for 20 minutes at 377C; thereaf- andreverseCAGGAGAGGTGCACGGTCCCATT;TNFRtypeII:for-
ward CTCAGAGAATACTATGACCAG and reverse CCTGCAAAT- ter, 200 mL of 10% formaldehyde solution were added. The ﬁxed
cell suspensions were examined at 4001 magniﬁcation. At least ATCCGTGGATG.
The ampliﬁcation proﬁles were 1* at 947C, 1* at 607C, 1* at 727C 200 cells were counted in each preparation. Cells deviating from a
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spontaneous polarization (Fig 1A), and locomotion (Fig 1B)
of B lymphocytes were enhanced in a statistically signiﬁcant
manner by the exposure to 1 and 10 ng/mL rTNF (Fig 1A).
At higher rTNF concentrations (100 and 1,000 ng/mL) B-
cell polarization and locomotion decreased approximately to
the levels observed in the absence of the cytokine (Fig 1A
and B). On the basis of the above experiments, the concentra-
tion of 1 ng/mL rTNF was chosen for all the subsequent
tests.
The B-cell–directed chemoattractant properties of rTNF
were further documented by two additional pieces of evi-
dence. First, when B cells were incubated with or without
rTNF, ﬁxed and analyzed by ﬂow cytometry, a clear-cut
shift of the FSC proﬁle was observed in cells exposed to
rTNF (Fig 2B) but not in control cells (Fig 2A). This ﬁnding
showed objectively that rTNF induced polarization of ton-
sillar B lymphocytes.
Second, experiments were performed to compare the che-
moattractant properties of rTNF to those of rIL-4, an inducer
of B-cell locomotion.
29,33 rIL-4 caused a low-grade enhance-
ment of B-cell responses in both polarization and locomotion
assays (% polarized cells: in absence of rIL-4  16.5 { 3.1,
in presence of 100 U/mL rIL-4  20.5 { 2.6, means { 1
SE, n  4, P  .4857; micrometers traveled: in absence of
rIL-4  52.2 { 5.3, in presence of 100 U/mL rIL-4  69.8
{ 8.5, means { 1 SE, n  4, P  .3429) as compared to
rTNF (see Fig 1A and B). When tested in the collagen inva-
sion assay that is classically used in cell migration studies,
29
both rTNF and rIL-4 increased signiﬁcantly the spontaneous
ability of B cells to invade collagen (Fig 3).
In subsequent studies, we investigated whether the en- Fig 1. Dose-response curves of puriﬁed tonsillar B cells to rTNF
hancement of B-cell migration induced by rTNF was due to in polarization and locomotion assays. B lymphocytes were puriﬁed
an increased rate of locomotion and/or to a true chemotactic and tested as described in Materials and Methods in polarization (A)
and locomotion (B) assays. Results are means ï SE from four to six TNF-dependent cell response. To this end, experiments mak-
different experiments. * P ò .05, ** P ò .01, Kruskal-Wallis nonpara- ing use of different rTNF concentrations above and below
metric ANOVA analysis.
the ﬁlters were performed (checkerboard analysis). As sum-
marized in Table 1, absolute rTNF concentrations (absence
of a cytokine gradient) enhanced the cell migration rate in for TNF; 1* at 947C and 2* at 687C for TNFR type I; 1* at 947C, 1*
a dose-dependent manner, suggesting chemokinetic proper- at 557C, 1* at 727C for TNFR type II. All the ampliﬁcations were
ties of the cytokine. In particular, 1 ng/mL rTNF above and carried out for 35 cycles. The ampliﬁed products were visualized
on a 2% agarose gel stained with ethidium bromide. below the ﬁlter stimulated cell migration by 45.8 { 9.9%
TNF assay. Forty-eight–hour culture supernatants from the puri- (mean { 1 SE, n  3). However, cell migration was higher
ﬁed B-cell fractions were collected and frozen at 0807C until tested. in the presence of positive rTNF gradients. In fact, 1 ng/
TNF was tested using an enzyme-linked immunosorbent assay mL rTNF below the ﬁlter only (positive chemotactic assay
(ELISA) kit (Amersham, Milano, Italy) that has been calibrated to condition) enhanced the cell migration by 106.6 { 9.9%
detect as low as 15 pg/mL. (mean { 1 SE, n  3), suggesting a cytokine-dependent Statistical analysis. Data are expressed as the mean { 1 SE.
true chemotactic response of B cells. On the contrary, cell Differences among groups were determined by the nonparametric
migration in negative gradients was lower than calculated on Mann-Whitney U-test. Differences among groups in dose-response
the basis of the expected response to absolute concentration experiments were determined using Kruskal-Wallis nonparametric
alone. Finally, taking into account the cell migration actually analysis of variance (ANOVA) followed by Dunn’s test for multiple
comparison.
31,32 detected and the migration distance expected on the basis of
the chemokinesis alone, almost 50% (49.9 { 3.7 %, mean
RESULTS { 1 SE, n  3) of the locomotory activity triggered by 1
ng/mL rTNF in the positive chemotactic assay conditions Effects of rTNF on the polarization and chemotaxis of
was due to a true chemotactic response. These results suggest puriﬁed tonsillar B lymphocytes. Tonsillar B cells were
that rTNF induces both a chemokinetic and a chemotactic puriﬁed by sequential depletion of T cells, NK cells, and
B-cell response. macrophages and subsequently tested for their ability to un-
rTNF enhances the locomotion of puriﬁed tonsillar mem- dergo polarization and locomotion in the presence or absence
of different concentrations of rTNF (Fig 1A and B). The ory and naive, but not GC, B lymphocytes. As mentioned,
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mately half of them expressed the CD23 marker (not shown).
CD38
/, IgD
0 GC B cells were CD10
/, CD39
0, CD23
0 (not
shown). IgD
0, CD38
0 memory B lymphocytes were predom-
inantly CD39
/, IgG
/, CD23
0, CD10
0 (not shown).
11,12
Next, memory, naive and GC B lymphocyte populations
were tested for their locomotor ability in the presence or
absence of rTNF (Fig 4). Memory, naive and GC B lympho-
cytes all migrated spontaneously (Fig 4). Upon incubation
with rTNF, memory and naive, but not GC, B lymphocytes
exhibited a signiﬁcant (P  .05) increase in their locomotion
as compared to the corresponding unstimulated B-cell frac-
tions (Fig 4). Furthermore, in the presence of rTNF, both
memory and naive B lymphocytes displayed a signiﬁcantly
higher degree of locomotion (P  .05) than GC B cells (Fig
4). Finally, memory B cells migrated faster (P  .05) than
naive B cells in the presence of rTNF (Fig 4).
Since GC B lymphocytes are highly susceptible to sponta-
neous apoptosis, the possibility that their failure to migrate
in response to rTNF (Fig 4) was related to the poor viability
was investigated. To this end, in three different experiments,
GC B cells were stained with trypan blue immediately before
being subjected to locomotor assays and after a 2-hour incu-
bation; the viability of these cell fractions was consistently
higher than 90% at both time intervals (data not shown).
Fig 2. Flow cytometric analysis of TNF-induced B lymphocyte po-
larization. B cells were incubated without (A) or with (B) 1 ng/mL
rTNF as detailed in the Materials and Methods and analyzed by ﬂow
cytometry. One representative experiment out of the four carried out
is shown. Staining with a CD20 MoAb showed that 98% of test cells
were B lymphocytes (not shown).
GC, naive, and memory B lymphocytes can be isolated ac-
cording to the expression of distinctive immunophenotypic
markers. In particular, naive B cells express surface IgD but
not CD38, the bulk of GC B cells are CD38
/, IgD
0, whereas
memory B cells are IgD
0, CD38
0 cells.
7,8,11,12
To investigate the effects of rTNF on the locomotion of
Fig 3. Collagen gel invasion by puriﬁed tonsillar B cells in the the above B-cell subsets, total tonsillar B cells were ﬁrst
presence or absence of rTNF or rIL-4. Results are expressed as mi- separated into IgD
/ and IgD
0 cells.
12 IgD
0 cells were further
crometers travelled by the two faster cells from the top of the gels. fractionated into the CD38
/ and CD38
0 subsets.
12 Consistent Nil  no cytokine; rTNF ! 1 ng/mL; rIL-4 ! 100 U/mL. Incubation
with previous reports,
11,12 most IgD
/ naive B cells were time ! 10 hours. Results are means ï 1 SE from four experiments.
*P ò .05, nonparametric Mann-Whitney U-test. CD39
/, IgM
/, IgG
0, CD38
0, CD10
0, whereas approxi-
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Table 1. Checkerboard Assay of Tonsillar B Cells in Response to rTNF
Distance Migrated (mm in 2 h) by Leading Front of Cell
rTNF (ng/mL) Below the Filter
0 0.1 1
rTNF (ng/mL) above the ﬁlter:
0 36.9 { 4.6 54.1 { 3.8 (38.7 { 4.6) 76.5 { 11.2 (41.6 { 6.9)
0.1 38.8 { 4.2 (43.4 { 3.9) 48.1 { 3.5 55.9 { 3.6 (49.3 { 4.4)
1 39.4 { 1.1 (50.5 { 6.1) 38.0 { 6.1 (52.3 { 6.2) 53.6 { 7.0
Results are expressed as mean { SE, n  3. Figures in parentheses show the calculated distance migrated if cells would have not responded
to the gradient of rTNF, but only to absolute concentration.
Expression of type I and type II TNFR on memory, naive, TNFR I) and the utr-1 (anti-TNFR II) MoAbs. All of the
staining procedures were performed after stripping of TNF and GC tonsillar B lymphocytes. TNF binds to two differ-
ent surface receptors which are known as type I or p55 bound in vivo to its receptors by cell treatment with an acidic
solution.
23 In four different experiments: (1) memory B cells and type II or p75 receptors, respectively.
34-36 Therefore, in
subsequent experiments, the expression of type I and type expressed both type I (range 30% to 40%) and type II (range
27% to 36%) TNFRs; (2) naive B cells also expressed the II TNFRs on the surface of memory, naive, and GC B cells
was investigated by ﬂow cytometry using the htr-9 (anti- two TNFRs (type I: range 5% to 15%; type II: range 8% to
16%), and (3) GC B cells did not display any expression of
either receptor. Figure 5 shows the FACS proﬁle of one
representative experiment.
The ﬁnding that GC B cells did not express TNFRs on
the cell surface raised the possibility that the failure of rTNF
to bind to its cellular receptors was involved in the migratory
unresponsiveness of GC B lymphocytes to the cytokine.
Nonetheless, when type I and type II TNFR gene expression
was investigated in puriﬁed GC B-lymphocyte fractions by
RT-PCR, the transcripts of both genes were consistently de-
tected (Fig 5).
Selective involvement of type II TNFR in the TNF-medi-
ated enhancement of memory and naive B-cell locomotion.
In further experiments, the involvement of TNFRs in the
TNF-mediated triggering of B-cell locomotion was investi-
gated. Memory and naive tonsillar B cells were puriﬁed as
above and incubated with MoAbs to TNFR I, TNFR II,
or with an isotype-matched MoAb of irrelevant speciﬁcity
(control). The two B-cell fractions were next washed and
tested for locomotor ability in the presence or absence of
rTNF (Fig 6A and B). The anti-TNFR II MoAb reduced the
TNF-dependent locomotion of both memory and naive B
lymphocytes to the levels observed in the absence of rTNF
(Fig 6A and B). In contrast, no decrease in TNF-induced
locomotion was observed on incubation of the two cell frac-
tions with the anti-TNFR I MoAb (Fig 6A and B). The
inhibition of TNF-induced migration by anti-TNFR MoAbs
tested in combination was comparable to that observed in
the experiments with the anti-TNFR II MoAb alone (not
shown). The anti-TNFR MoAbs tested alone or in combina-
tion or the control antibody had no effect on the spontaneous
Fig 4. Locomotion of memory, naive, and GC B lymphocytes. Lo- migration of memory and naive B cells (not shown).
comotory activity of IgD
ìCD38
ì memory cells, IgD
" naive cells, and Taken together, these results show the selective involve- IgD
ìCD38
" GC B cells in the presence (h) or absence (j)o f1n g
ment of the TNFR II in the TNF-mediated enhancement of rTNF. Data are means ï SE from four experiments. In the presence
of rTNF, memory and naive, but not GC, B cells migrated faster than memory and naive B-cell locomotion.
the corresponding unstimulated cell fractions (P ò .05, nonparamet- Expression of the TNF gene in naive, memory, and GC
ric Mann-Whitney U-test). Furthermore, in the presence of rTNF, tonsillar B lymphocytes. Next, the expression of the TNF memory and naive B lymphocytes displayed a signiﬁcantly higher
gene in naive, memory, and GC tonsillar B cells was investi- degree of locomotion than GC B cells (P ò .05) and memory B cells
migrated faster than naive B cells (P ò .05). gated. The aim of these experiments was to assess the poten-
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Fig 5. Expression of type I and type II TNFR in memory, naive, and GC B lymphocytes. Cells were stained with 10 mg/mL htr-9 (anti-TNFR
I), 10 mg/mL utr-1 (anti-TNFR II) MoAbs or an isotype-matched irrelevant MoAb (control) and analyzed by ﬂow cytometry. The FACS proﬁles
are from one representative experiment of the four performed. RT-PCR analysis of TNFR gene expression in GC B cells is shown on the right
(M ! marker; lane 1 ! negative control; lanes 2 through 4 correspond to three different GC B-cell samples). The size of the expected fragments
is indicated on the left.
tial contribution of B-cell derived TNF to the TNF-depen-
dent enhancement of memory and naive B-cell migration.
Total RNA, that had been extracted from freshly isolated
naive, memory, and GC B lymphocytes, was reverse tran-
scribed and analyzed by RT-PCR. TNF mRNA was ex-
pressed in the three B-cell subsets (Fig 7A). To determine
whether TNF mRNA was translated into the corresponding
protein, puriﬁed naive, memory, and GC B lymphocytes
were cultured for 24 hours in the presence or absence of
PMA and A23187 or of the CD40 MoAb and rIL-4. rTNF
was then tested in culture supernatants by ELISA. The results
of three experiments are shown in Fig 7B. No TNF was
detected in the supernatants from the unstimulated cultures,
whereas PMA and A23187 induced the release of immunore-
active TNF by naive, memory, and GC B lymphocytes (Fig
7B). The CD40 MoAb and IL-4 were ineffective at triggering
TNF release by any of the three B-cell subsets (not shown),
in accordance with that reported by Worm et al
37 using total
tonsillar B lymphocyte suspensions. Fig 6. Involvement of TNFRs in the TNF-induced enhancement of
memory and naive B-cell locomotion. Freshly puriﬁed memory (A)
and naive (B) B cells were treated with anti-TNFR I, anti-TNFR II,
DISCUSSION or with an isotype-matched MoAb of irrelevant speciﬁcity (control
MoAb). Cells were subsequently tested in locomotor assays in the In this study we have investigated the in vitro migratory
absence (Nil) or in the presence of 1 ng/mL rTNF. Results are means properties of human tonsillar B lymphocytes, either in the ï SE from six to seven different experiments. *P ò .05, **P ò .005,
presence or absence of rTNF. The cytokine caused a signiﬁ- versus isotype-matched MoAb and rTNF-treated control, nonpara-
metric Mann-Whitney U-test. cant increase in the polarization and locomotion of unfrac-
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Fig 7. TNF expression in memory, naive, and GC
B lymphocytes. (A) RT-PCR analysis of TNF gene ex-
pression in puriﬁed memory, naive, and GC B-cell
fractions. The size of the expected fragments is indi-
cated on the right. (B) TNF production by puriﬁed
memory, naive, and GC B lymphocytes after 48-
hours culture in the absence (j) or presence (h)o f
PMA and A23187. TNF in culture supernatants was
assayed by ELISA. Results are means ï SE from
three experiments and are expressed as pg/mL.
tionated B cells, as assessed by different techniques includ- responsiveness of the three B-cell subsets to rTNF. Both
type I and type II TNFRs were detected by ﬂow cytometry ing ﬂow cytometry, the leading front method and the
collagen invasion assay. Thus, rTNF adds to the list of cyto- on the surface of freshly isolated memory and naive B cells,
but the percentage of positive cells was deﬁnitely higher in kines that inﬂuence the in vitro migration of human B lym-
phocytes either positively, such as IL-4
29,33 and IFN-g
33 or the memory than in the naive B-lymphocyte population. As
for GC B cells, ﬂow cytometric analyses failed consistently negatively, such as IL-10.
38 In this respect it is noteworthy
that rIL-4 and rTNF displayed a comparable chemotactic to detect any surface expression of TNFRs, but the same
cell fractions were found to produce TNFR I and II mRNA activity versus tonsillar B lymphocytes in the collagen inva-
sion assay. by RT-PCR.
The following hypotheses may be envisaged to try to ex- Checkerboard experiments showed that rTNF induced a
true B-cell chemotaxis suggesting that rTNF itself, rather plain such apparent discrepancy: (1) TNFRs are indeed not
expressed on the surface of GC B cells due to, for example, than other cytokines possibly induced by cell incubation with
rTNF,
39-42 was the driving force for B-lymphocyte locomo- mRNA instability or other posttranscriptional mechanisms.
This hypothesis may be supported by previous immunohisto- tion.
Puriﬁed tonsillar B-cell subsets displayed a hierarchy in chemical studies on tonsillar tissue sections showing that,
within the GC, only FDC stained for TNFR I, but not TNFR their migratory properties. Memory B lymphocytes exhibited
the highest spontaneous locomotion and the strongest che- II
43; (2) TNFRs are expressed on the surface of GC B cells
at a density that is below the threshold of ﬂow cytometry motactic response to rTNF; naive B cells also migrated under
the same experimental conditions, but they were slower than detection. According to this hypothesis, the few molecules
of TNFRs would be insufﬁcient to allow a migratory re- memory B cells. Finally, GC B cells, although migrating
spontaneously, were totally refractory to rTNF stimulation. sponse to rTNF; (3) surface TNFRs cannot be detected be-
cause they are internalized or shed upon binding in vivo to The expression of surface TNFRs paralleled the in vitro
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their natural ligands, ie, TNF
44 and LT-a. In this respect, it the observation that most of the TNF newly synthesized by
B cells upon CD40 cross-linking is retained at the surface is of note that FDC produce TNF in vivo, thus replenishing
the GC with the cytokine.
43,45,46 of activated B cells as a membrane-bound molecule.
37 A
transmembrane form of TNF has been shown on the surface Whatever the mechanism, it is tempting to speculate that
GC B lymphocytes downregulate the surface expression of of human activated CD4
/ T lymphocytes where the cytokine
provides a costimulatory signal for B-cell activation.
50 TNFRs and perhaps of other cytokine receptors to minimize
the inﬂuence of exogenous stimuli in a specialized microen- Therefore, it may be hypothesized that not only soluble, but
also membrane-bound TNF is involved in the triggering of vironment where proliferation, antigen-driven selection and
hypermutation of Ig V genes take place.
4-7 B-cell locomotion.
In conclusion, the identiﬁcation of TNF as a novel chemo- The above experiments raised the question of what type(s)
of TNFR was involved in the TNF-mediated enhancement tactic factor for human B lymphocytes opens up new per-
spectives for a better knowledge of the mechanisms govern- of memory and naive B-lymphocyte locomotion. To address
this issue, the latter cell fractions were incubated with anti- ing B-cell migration in normal and pathologic conditions,
eg, autoimmune and lymphoproliferative disorders. Further TNFR I or II MoAbs before being tested. Blocking of TNFR
II, but not TNFR I, abrogated the responsiveness of both studies along these directions are now in progress.
memory and naive B lymphocytes to rTNF but left the spon-
taneous migration of the two cell subsets unaltered. ACKNOWLEDGMENT
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